Search clinical trials for: MembraGel

Total 11398 results

Northwestern University
Gilead Sciences

Completed

Ranolazine and Pulmonary Hypertension

Pulmonary Arterial Hypertension | Angina

United States
University of Louisville
Takeda

Completed

Effects of Lubiprostone on Small Bowel and Colonic Bacteria: A Correlation Study With Segmental and Whole Gut Transit

Constipation

United States
University of Arkansas
Takeda

Terminated

Lubiprostone as a Treatment for Constipation in Parkinson's Disease

Parkinson's Disease | Constipation

United States
GlaxoSmithKline
Bausch Health Americas, Inc.

Completed

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy (RESTORE1)

Seizures

United States, Canada, Argentina, Brazil, Mexico
SVS Institute of Dental Sciences

Completed

Clinical, Anti-Inflammatory And Anti-Infective Properties Of Amniotic Membranes Used For Guided Tissue Regeneration

Chronic Periodontitis

India
Vertex Pharmaceuticals Incorporated
Cystic Fibrosis Foundation

Completed

Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have a Non-G551D CF Transmembrane Conductance Regulator (CFTR) Gating Mutation (KONNECTION)

Cystic Fibrosis

United States, France, Belgium
GlaxoSmithKline

Completed

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures (IR)

Epilepsy

Bulgaria, Belgium, Thailand, Denmark, Russian Federation, Italy, Spain, Ukraine, Netherlands, Germany, France, Poland
Gilead Sciences

Completed

An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)

Chronic Angina

United States
University of Alabama at Birmingham

Recruiting

Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations

Cystic Fibrosis

United States
East Carolina University
Gilead Sciences

Withdrawn

Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries

Myocardial Ischemia | Coronary Artery Disease | Arteriosclerosis | Chronic Stable Angina

United States
University of Southern Denmark
Odense University Hospital; Fonden til Lægevidenskabens Fremme; Sygehus Lillebaelt and other collaborators

Completed

Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking Technique (MUST)

Multiple Sclerosis

Denmark
University Hospital, Strasbourg, France

Completed

Observational Study of Glucose Tolerance Abnormalities in Patient With Cystic Fibrosis Homozygous for Phe 508 Del CFTR Treated by Lumacaftor-Ivacaftor (GLUCORRECTOR)

Cystic Fibrosis Homozygous for Phe 508 Del CFTR | Glucose Intolerance or Newly Diagnosis Diabetes

France
Carmel Medical Center

Completed

Real Life Evaluation of the Multi-organ Effects of Lumacaftor/Ivacaftor on F508del Homozygous Cystic Fibrosis Patients.

Cystic Fibrosis
University of South Alabama
Takeda; Sucampo Pharmaceuticals, Inc.

Completed

Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy

Inflammatory Bowel Disease

United States
Genesis Pharma CNS & Specialty

Completed

Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis (FAMILY)

Multiple Sclerosis

Greece
Brigham and Women's Hospital

Completed

Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults (APIGLOSS)

Sleep Apnea, Obstructive

United States
Vertex Pharmaceuticals Incorporated

Completed

Study of Lumacaftor in Combination With Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

Cystic Fibrosis

United States, Canada
Emory University

Completed

The Effectiveness of Lubiprostone in Constipated Diabetics

Diabetes | Constipation

United States
Nobelpharma

Completed

The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin

Epilepsy

Japan
John Elfar

Not yet recruiting

4AP to Delay Carpal Tunnel Release (CTR) (CTR)

Carpal Tunnel Syndrome | Compression Neuropathy
The University of Texas Health Science Center at...

Recruiting

Palatal Donor Site Wound Healing Following Periodontal Plastic Surgery Using Amnion-Chorion Membrane

Palate; Wound

United States
The University of Western Australia
Osteology Foundation

Completed

Surgical Treatment of Peri-implantitis (STP)

Peri-Implantitis

Australia
University of Rochester
Gilead Sciences

Completed

Long-term Efficacy Study of Sodium Channel Blocker in LQT3 Patients

Long QT Syndrome

United States
Danish Headache Center

Completed

Phenytoin as Treatment for Acute Exacerbations of Trigeminal Neuralgia - a Prospective Systematic Study of 20 Patients

Trigeminal Neuralgia

Denmark
Vertex Pharmaceuticals Incorporated

Completed

Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study) (VOCAL)

Cystic Fibrosis

Netherlands, Italy, United Kingdom
University of Florida

Completed

Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome (IRMA)

Metabolic Syndrome | Stable Angina

United States
Vertex Pharmaceuticals Incorporated

Terminated

A Study to Evaluate Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Aged 3 Through 5 Years Who Have a Specified CFTR Gating Mutation

Cystic Fibrosis

United Kingdom, Canada, Australia
Dartmouth-Hitchcock Medical Center
Takeda Pharmaceuticals North America, Inc.

Completed

Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

United States
Harvey Hahn
Gilead Sciences

Terminated

Ranolazine Cardioprotection in PCI

Acute Coronary Syndrome

United States
Vertex Pharmaceuticals Incorporated

Completed

A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis

Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation

United States, France, United Kingdom, Germany, Spain, Belgium, Canada, Australia, Netherlands, Denmark, Czech Republic, Italy, Austria, Ireland, Sweden
Vertex Pharmaceuticals Incorporated
Cystic Fibrosis Foundation

Completed

Rollover Study of VX-770 in Cystic Fibrosis Subjects

Cystic Fibrosis

United States, France, United Kingdom, Germany, Canada, Czech Republic, Ireland, Australia
Vertex Pharmaceuticals Incorporated
Cystic Fibrosis Foundation

Completed

Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT) (KONDUCT)

Cystic Fibrosis

United States, United Kingdom
University of Arkansas
Takeda Pharmaceuticals North America, Inc.

Completed

Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis

Constipation | Cystic Fibrosis

United States
Chulalongkorn University

Completed

To Compare Fibrin Glue and Suture in Primary Pterygium Excision With Amniotic Membrane Transplantation

Pterygium

Thailand
Fondazione Policlinico Universitario Agostino Gemelli...

Withdrawn

Ranolazine a Potential New Therapeutic Application

Myocardial Stunning
University of California, Los Angeles
University of South Florida; University of Rochester

Withdrawn

4-Aminopyridine in Episodic Ataxia Type 2 (4AP in EA2)

Episodic Ataxia Type 2

United States
TSH Biopharm Corporation Limited

Completed

A TSHRN1201 Sub-study-To Evaluate the Effects of add-on Ranolazine on Exercise Tolerance and Angina Frequency

Angina

Taiwan
GlaxoSmithKline

Terminated

Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures

Epilepsy

Thailand, Korea, Republic of, Singapore, Hong Kong, Taiwan, Malaysia, Philippines
Vertex Pharmaceuticals Incorporated

Completed

Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease

Cystic Fibrosis | Advanced Lung Disease

United States
GlaxoSmithKline
Bausch Health Americas, Inc.

Completed

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy (RESTORE2)

Seizures

Spain, Australia, Israel, Ukraine, Belgium, United States, South Africa, Hungary, United Kingdom, France, Germany, Poland, Russian Federation
University of Rochester
Takeda

Completed

Lubiprostone in Patients With Multiple Sclerosis Associated Constipation

Multiple Sclerosis | Constipation

United States
Gilead Sciences

Terminated

Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy

Coronary Artery Disease | Pain | Peripheral Nervous System Diseases | Polyneuropathy

United States
Helwan University

Completed

Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease

NAFLD

Egypt
Sunnybrook Health Sciences Centre

Terminated

Randomized Trial Comparing Epiretinal Membrane Surgery With and Without Internal Limiting Membrane Removal

Epiretinal Membrane

Canada
OBS Pakistan

Unknown

Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine) (MIDA)

Chronic Stable Angina
Duke University
Gilead Sciences

Completed

Effects of Ranolazine and Exercise on Daily Physical Activity Trial (EREDA)

Chronic Stable Angina

United States
University of Oklahoma
Gilead Sciences

Terminated

Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion (GILEAD)

Atrial Fibrillation

United States
Concert Pharmaceuticals

Completed

Study to Evaluate Safety, Tolerability and PK of C-10355 and C-10358 in Healthy Subjects

Healthy

Australia
Vertex Pharmaceuticals Incorporated

Completed

A Phase 1 Study to Investigate the Food Effect of Lumacaftor in Combination With Ivacaftor

Cystic Fibrosis

United States
University of Arizona
National Institute of Neurological Disorders and Stroke (NINDS)

Not yet recruiting

4-AP Peripheral Nerve Crossover Trial

Peripheral Nerve Injury | Crush Injury

Search clinical trials for: MembraGel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations